Correlation Between Trevi Therapeutics and Alx Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Alx Oncology Holdings, you can compare the effects of market volatilities on Trevi Therapeutics and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Alx Oncology.

Diversification Opportunities for Trevi Therapeutics and Alx Oncology

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Trevi and Alx is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Alx Oncology go up and down completely randomly.

Pair Corralation between Trevi Therapeutics and Alx Oncology

Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 0.58 times more return on investment than Alx Oncology. However, Trevi Therapeutics is 1.72 times less risky than Alx Oncology. It trades about -0.14 of its potential returns per unit of risk. Alx Oncology Holdings is currently generating about -0.11 per unit of risk. If you would invest  436.00  in Trevi Therapeutics on November 2, 2024 and sell it today you would lose (46.00) from holding Trevi Therapeutics or give up 10.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Trevi Therapeutics  vs.  Alx Oncology Holdings

 Performance 
       Timeline  
Trevi Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Trevi Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Trevi Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Alx Oncology Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Alx Oncology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Alx Oncology is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Trevi Therapeutics and Alx Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Trevi Therapeutics and Alx Oncology

The main advantage of trading using opposite Trevi Therapeutics and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.
The idea behind Trevi Therapeutics and Alx Oncology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Content Syndication
Quickly integrate customizable finance content to your own investment portal